Literature DB >> 7391081

Autoactivation of human Hageman factor. Demonstration utilizing a synthetic substrate.

M Silverberg, J T Dunn, L Garen, A P Kaplan.   

Abstract

The kallikrein substrate H-D-Pro-Phe-Arg-p-nitroanilide was used in a direct spectrophotometric assay for activated Hageman factor (HF). An 80,000-dalton two-chain, disulfide-linked enzyme, termed HFa, and a 28,000-dalton Hageman factor cleavage product, HFf, were not distinguished in this assay and had a Km of 190 microM and kcat of 15/s. Treatment of HF with 10(-2) M diisopropylfluorophosphate yielded preparations containing 0.2 to 0.9% activated HF as assessed in plastic cuvettes. In quartz cuvettes, concave upward progress curves were obtained. Secondary plots of absorbance/time against time were also nonlinear and consistent with an increased rate of formation of activated enzyme. The curves varied with total protein content and synthetic substrate concentration in a manner consistent with autoactivation; increasing synthetic substrate competed with native HF for interaction with activated HF. Accelerated cleavage of surface-bound radiolabeled HF was demonstrated after incubation with HFa but not HFf, indicating that HFa is the form of active enzyme responsible for autocleavage. The autoactivation described herein may provide a sufficient initial concentration of activated HF to initiate the intrinsic coagulation, fibrinolytic, and kinin-forming cascade.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7391081

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

Review 1.  The blood compatibility challenge. Part 2: Protein adsorption phenomena governing blood reactivity.

Authors:  John L Brash; Thomas A Horbett; Robert A Latour; Pentti Tengvall
Journal:  Acta Biomater       Date:  2019-06-18       Impact factor: 8.947

Review 2.  Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent.

Authors:  Allen P Kaplan; Kusumam Joseph
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

Review 3.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  The initiation and effects of plasma contact activation: an overview.

Authors:  Lisha Lin; Mingyi Wu; Jinhua Zhao
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

5.  Sum Frequency Generation Studies on Bioadhesion: Elucidating the Molecular Structure of Proteins at Interfaces.

Authors:  Stéphanie Le Clair; Khoi Nguyen; Zhan Chen
Journal:  J Adhes       Date:  2009-08-01       Impact factor: 2.917

6.  The autoactivation of factor XII (Hageman factor) induced by low-Mr heparin and dextran sulphate. The effect of the Mr of the activating polyanion.

Authors:  M Silverberg; S V Diehl
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

7.  Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.

Authors:  Kusumam Joseph; Baby G Tholanikunnel; Bethany Wolf; Konrad Bork; Allen P Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-09-26       Impact factor: 10.793

Review 8.  Cross-talk between the complement and the kinin system in vascular permeability.

Authors:  Fleur Bossi; Ellinor I Peerschke; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Immunol Lett       Date:  2011-07-06       Impact factor: 3.685

9.  Modulation of the human monocyte binding site for monomeric immunoglobulin G by activated Hageman factor.

Authors:  P Chien; R A Pixley; L G Stumpo; R W Colman; A D Schreiber
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

10.  Ir-CPI, a coagulation contact phase inhibitor from the tick Ixodes ricinus, inhibits thrombus formation without impairing hemostasis.

Authors:  Yves Decrem; Géraldine Rath; Virginie Blasioli; Philippe Cauchie; Séverine Robert; Jérôme Beaufays; Jean-Marie Frère; Olivier Feron; Jean-Michel Dogné; Chantal Dessy; Luc Vanhamme; Edmond Godfroid
Journal:  J Exp Med       Date:  2009-10-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.